Biotech News
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
ir.cytomx.com2026-05-06 15:07 EST
SOUTH SAN FRANCISCO, Calif. , Nov. 13, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy , D.Phil ., chief executive officer and chairman, will participate in a fireside chat at